High triglyceride-glucose index is associated with poor cardiovascular outcomes in Chinese acute coronary syndrome patients without diabetes mellitus who underwent emergency percutaneous coronary intervention with drug-eluting stents

被引:17
作者
Zhang, Yong [1 ]
Chu, Chao [1 ]
Zhong, Zhong [2 ]
Luo, Yong-bai [1 ]
Ning, Fei-fei [1 ]
Guo, Ning [1 ]
机构
[1] Xi An Jiao Tong Univ, Dept Cardiovasc Med, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China
[2] Weinan Cent Hosp, Dept Cardiovasc Med, Weinan, Shaanxi, Peoples R China
关键词
triglyceride-glucose index; insulin resistance; acute coronary syndrome; emergency percutaneous coronary intervention; major adverse cardiovascular and cerebrovascular event; ST-SEGMENT ELEVATION; INSULIN-RESISTANCE; TYG INDEX; NONDIABETIC PATIENTS; FASTING GLUCOSE; ARTERY-DISEASE; SENSITIVITY; RESTENOSIS; PREDICTION; INFARCTION;
D O I
10.3389/fendo.2023.1101952
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPrevious research has supported the association between the triglyceride-glucose index (TyG index) and the incidence and prognosis of cardiovascular disease. However, the association between the TyG index and the prognosis of patients with acute coronary syndrome (ACS) without diabetes mellitus (DM) who underwent emergency percutaneous coronary intervention (PCI) with drug-eluting stents (DESs) has not been thoroughly investigated, and these patients may easily be neglected. Therefore, this study aimed to investigate the association between the TyG index and major adverse cardiovascular and cerebrovascular events (MACCEs) in Chinese ACS patients without DM who underwent emergency PCI with DES. MethodsThe total number of ACS patients without DM who underwent emergency PCI with DES for this study was 1650. Ln [fasting triglycerides (mg/dL) xfasting plasma glucose (mg/dL)/2] is the formula used to calculate the TyG index. According to the TyG index, we classified the patients into two groups. The frequency of the following endpoint events was calculated and compared between the two groups: all-cause death, non-fatal myocardial infarction (MI), non-fatal ischemia stroke, ischemia-driven revascularization and cardiac rehospitalization. ResultsAfter a median of 47 months of follow-up [47 (40, 54)], 437 (26.5%) endpoint events were recorded in total. The TyG index was further demonstrated to be independent of MACCE by multivariable Cox regression analysis (hazard ratio [HR], 1.493; 95% confidence interval [CI], 1.230-1.812; p<0.001). The TyG index >= 7.08 group had a considerably greater incidence of MACCE (30.3% vs. 22.7% in the TyG index<7.08 group, p<0.001), cardiac death (4.0% vs. 2.3% in the TyG index<7.08 group, p=0.047), and ischemia-driven revascularization (5.7% vs. 3.6% in the TyG index<7.08 group, p=0.046) than the TyG index<7.08 group. Between the two groups, there was no discernible difference in all-cause death (5.6% vs. 3.8% in the TyG index<7.08 group, p=0.080), non-fatal MI (1.0% vs. 0.2% in the TyG index<7.08 group, p=0.057), non-fatal ischemic stroke (1.6% vs. 1.0% in the TyG index<7.08 group, p=0.272), and cardiac rehospitalization (16.5% vs. 14.1% in the TyG index<7.08 group, p=0.171). ConclusionFor ACS patients without DM who received emergency PCI with DES, the TyG index might be an independent predictor of MACCE.
引用
收藏
页数:11
相关论文
共 45 条
[1]   Current Treatment of In-Stent Restenosis [J].
Alfonso, Fernando ;
Byrne, Robert A. ;
Rivero, Fernando ;
Kastrati, Adnan .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (24) :2659-2673
[2]  
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S011, 10.2337/dc12-s011, 10.2337/dc11-S011, 10.2337/dc13-S067, 10.2337/dc11-S062, 10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc12-s064, 10.2337/dc13-S011]
[3]   Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[4]   Adiposopathy, Diabetes Mellitus, and Primary Prevention of Atherosclerotic Coronary Artery Disease: Treating "Sick Fat" Through Improving Fat Function with Antidiabetes Therapies [J].
Bays, Harold E. .
AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (09) :4B-12B
[6]   Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population - The Bruneck study [J].
Bonora, Enzo ;
Egger, Georg ;
Kiechl, Stefan ;
Meigs, James B. ;
Willeit, Johann ;
Bonadonna, Riccardo C. ;
Oberhollenzer, Friedrich ;
Muggeo, Michele .
DIABETES CARE, 2007, 30 (02) :318-324
[7]   Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes [J].
Cannon, Christopher P. ;
Blazing, Michael A. ;
Giugliano, Robert P. ;
McCagg, Amy ;
White, Jennifer A. ;
Theroux, Pierre ;
Darius, Harald ;
Lewis, Basil S. ;
Ophuis, Ton Oude ;
Jukema, J. Wouter ;
De Ferrari, Gaetano M. ;
Ruzyllo, Witold ;
De Lucca, Paul ;
Im, KyungAh ;
Bohula, Erin A. ;
Reist, Craig ;
Wiviott, Stephen D. ;
Tershakovec, Andrew M. ;
Musliner, Thomas A. ;
Braunwald, Eugene ;
Califf, Robert M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (25) :2387-2397
[8]   Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents [J].
Di Pino, Antonino ;
DeFronzo, Ralph A. .
ENDOCRINE REVIEWS, 2019, 40 (06) :1447-1467
[9]   Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance [J].
Du, Tingting ;
Yuan, Gang ;
Zhang, Muxun ;
Zhou, Xinrong ;
Sun, Xingxing ;
Yu, Xuefeng .
CARDIOVASCULAR DIABETOLOGY, 2014, 13
[10]   Updates on Acute Coronary Syndrome [J].
Eisen, Alon ;
Giugliano, Robert P. ;
Braunwald, Eugene .
JAMA CARDIOLOGY, 2016, 1 (06) :718-730